Booz Allen Hamilton Holding Corp financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Booz Allen Hamilton Holding Corp files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	5,809	6,172	6,704	7,464	7,859	8,364	9,259	10,662	11,980	11,217
Cost of revenue	2,679	2,866	3,100	3,379	3,658	3,900	4,305	4,921	5,419	5,305
Gross profit	3,131	3,306	3,604	4,085	4,201	4,464	4,954	5,741	6,561	5,912
General and administrative	814	856	928	1,036	1,037	1,159	1,533	1,281	1,246	1,266
Operating income	506	520	602	669	754	685	447	1,014	1,370	1,033
Interest expense	62.3	82.3	89.5	97	81.3	92.4	120	173	186	212
Other non-operating income	-18.1	-7.42	2.53	7.19	-10.7	11.2	31	-13	17	13
Pre-tax income	426	430	515	579	662	604	368	854	1,219	862
Income tax	165	128	96.9	96.8	53.5	137	97	248	284	11
Net income to minority interests				0	0	-0.16	-1	0	0
Net income	261	302	419	483	609	467	272	606	935	851
EBITDA	566	584	671	750	839	831	612	1,178	1,535	1,196
EPS, basic	1.74	2.05	2.94	3.43	4.40	3.46	2.04	4.61	7.28	6.92
EPS, diluted	1.72	2.03	2.91	3.41	4.37	3.44	2.03	4.59	7.25	6.90
Shares, basic (weighted)	148	146	142	140	138	134	132	130	128	122
Shares, diluted (weighted)	150	148	143	141	139	135	133	131	128	122
Dividend per share		0.70	0.80	1.04	1.30	1.54	1.76	1.92	2.08	2.24

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	217	287	284	742	991	696	405	554	885	728
Receivables	992	1,134	1,330	1,459	1,412	1,623	1,775	2,047	2,271	2,063
Other current assets	85.3	71.3	85	127	233	127	108	138	157	170
Total current assets	1,294	1,492	1,699	2,328	2,636	2,446	2,288	2,739	3,313	2,961
Property, plant and equipment	139	152	172	208	205	202	195	188	177	171
Lease right-of-use assets			0	240	239	227	188	174	178	147
Goodwill	1,571	1,581	1,581	1,581	1,581	2,022	2,338	2,344	2,405	2,399
Intangible assets	272	279	287	301	307	647	686	601	563	509
Other non-current assets	85.6	103	91.8	135	531	449	282	291	344	637
Total assets	3,373	3,607	3,832	4,794	5,500	6,026	6,551	6,564	7,312	7,118
Accounts payable	269	340	418	433	372	540	598	653	693	594
Accrued liabilities	235	218	247	265	295	363	719	20	33	35
Deferred revenue										28
Short-term debt	193	63.1	57.9	178	77.9	68.4	41.3	62	83	19
Total current liabilities	1,101	1,029	1,179	1,328	1,291	1,534	1,897	1,692	1,846	1,663
Long-term debt	1,470	1,755	1,702	2,008	2,279	2,732	2,771	3,350	3,915	3,921
Lease liabilities			0	270	263	247	198	182	180	139
Other non-current liabilities	216	241	231	244	231	147	140	293	368	290
Total liabilities	2,800	3,044	3,156	3,938	4,428	4,979	5,559	5,517	6,309	6,013
Total debt	1,663	1,819	1,760	2,186	2,357	2,800	2,812	3,412	3,998	3,940
Paid-in capital	303	347	402	468	558	656	769	909	1,042	1,155
Retained earnings	478	691	995	1,331	1,758	2,015	2,051	2,404	3,070	3,644
Treasury stock	-192	-461	-711	-898	-1,216	-1,635	-1,860	-2,278	-3,082	-3,673
Other comprehensive income	-17.1	-15.1	-11.2	-46	-29.8	8.59	29.3	10	-29	-23
Shareholders' equity	585	562	675	856	1,071	1,046	992	1,047	1,003	1,105
Minority interests					0	0.65	0
Total equity	585	562	675	856	1,071	1,048	992	1,047	1,003	1,105
Total liabilities and equity	3,373	3,607	3,832	4,794	5,500	6,026	6,551	6,564	7,312	7,118
Shares outstanding	149	143	140	139	136	133	132	130	125	120

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	261	302	419	483	609	467	271	606	935	851
Depreciation and amortization	59.5	64.8	68.6	81.1	84.3	146	165	164	165	163
Stock-based compensation	21.2	23.3	31.3	43.3	59.8	69.8	80	95	94	69
Deferred income tax	21	8.96	23	65.4	232	-130	-354	-101	-91	35
Change in receivables	-95.2	-126	-196	-129	47.1	-155	-130	-270	-206	207
Change in payables	14.8	53.5	108	48.3	-31.5	195	410	-282	-66	-86
Cash from operations	382	369	500	551	719	737	603	259	1,009	1,041
Capital expenditures	-53.9	-78.4	-94.7	-128	-87.2	-80	-76	-67	-98	-90
Acquisitions	-248	-19.1		0	0	-780	-440	0	-97
Purchases of investments				0	0	-7	-5	-24	-37
Cash from investing	-301	-96.5	-89.2	-128	-158	-868	-468	-91	-218	-300
Debt issued	1,019	468	102	498	691	487	415	636	644
Debt repaid	-968	-317	-171	-76.9	-528	-112	-417	-541	-262	-62
Stock issued	6.31	8.91	11.3	15	19.4	23.4	25	44	38	45
Share buybacks	-46.5	-270	-253	-182	-313	-419	-224	-404	-812	-598
Dividends paid	-92.9	-103	-114	-147	-181	-209	-236	-254	-268	-276
Cash from financing	-51.5	-203	-413	34.6	-311	-164	-426	-19	-460	-898
Net change in cash	29.9	69.5	-2.97	458	249	-295	-291	149	331	-157
Free cash flow	328	291	405	423	631	657	527	192	911	951
Interest paid	49.1	62.5	76.7	84.1	61	64.7	116	156	186	191
Income taxes paid	89.6	128	52.5	110	177	127	256	336	379	103

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $72.95 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	53.0%	Gross profit / revenue.
Operating margin	9.5%	Operating income / revenue.
EBITDA margin	11.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	8.1%	Pre-tax income / revenue.
Net margin	7.0%	Net income / revenue.
FCF margin	10.1%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	10.8%	Cash from operations / revenue.
Effective tax rate	13.3%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	64.7%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	10.2%	Net income / average total assets.
Return on invested capital (ROIC)	19.9%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	0.6%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.8%	Capital expenditures / revenue.
D&A / revenue	1.5%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-6.4%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	6.6%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	7.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-9.9%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	6.1%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	7.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-24.6%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	32.2%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	6.5%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-22.1%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	25.0%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	7.4%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-9.0%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	46.3%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	6.9%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-4.8%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	50.4%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	9.6%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	3.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	20.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	7.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	4.4%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	21.7%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	8.5%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	7.7%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	8.4%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	11.5%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	10.2%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	3.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	0.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-2.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	2.8%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	5.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-4.6%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-2.7%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-2.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.59x	Current assets / current liabilities.
Quick ratio	1.50x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.28x	(Cash + short-term investments) / current liabilities.
Debt / equity	3.27x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	51.7%	Total debt / total assets.
Liabilities / assets	84.2%	Total liabilities / total assets.
Net debt	$3.40B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.78x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$1.13B	Current assets - current liabilities.
Goodwill and intangibles / assets	41.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$1.92B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.46x	Revenue / average total assets.
Fixed asset turnover	66.4x	Revenue / average property, plant and equipment.
Receivables turnover	4.78x	Revenue / average receivables.
Days sales outstanding	76 days	365 x average receivables / revenue.
Days payables	47 days	365 x average accounts payable / cost of revenue.
FCF conversion	143.4%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	7.2%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$6.47	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$92.30	Revenue / diluted weighted shares.
FCF per share	$9.29	Free cash flow / diluted weighted shares.
Operating cash flow per share	$10.01	Cash from operations / diluted weighted shares.
Book value per share	$9.99	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$15.99	Tangible book value / shares outstanding.
Cash per share	$4.49	(Cash + short-term investments) / shares outstanding.
Payout ratio	35.9%	Dividends paid / net income, when net income is positive.
Dividends / FCF	25.0%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	43.8%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$8.77B	Share price x shares outstanding.
Enterprise value	$12.17B	Market cap + total debt - cash - short-term investments.
P/E	11.3x	Market cap / net income. Only when net income is positive.
P/S	0.79x	Market cap / revenue.
P/B	7.30x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	7.86x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	7.29x	Market cap / cash from operations, when positive.
EV/Sales	1.10x	Enterprise value / revenue.
EV/EBIT	11.5x	Enterprise value / operating income, when both are positive.
EV/EBITDA	9.95x	Enterprise value / EBITDA, when both are positive.
EV/FCF	10.9x	Enterprise value / free cash flow, when both are positive.
FCF yield	12.7%	Free cash flow / market cap.
Earnings yield	8.9%	Net income / market cap (the inverse of P/E).
Dividend yield	3.2%	Dividends paid over the period / market cap.
Shareholder yield	8.8%	(Dividends paid + share buybacks) / market cap.
PEG	0.22x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was Booz Allen Hamilton Holding Corp's revenue in fiscal 2026?

Booz Allen Hamilton Holding Corp reported revenue of $11.22B for fiscal 2026, 6.4% lower than the year before.

Was Booz Allen Hamilton Holding Corp profitable in fiscal 2026?

Yes. Net income was $851.0M, a net margin of 7.6%.

How much free cash flow did Booz Allen Hamilton Holding Corp generate in fiscal 2026?

Cash from operations of $1.04B minus capital expenditures of $90.0M left free cash flow of $951.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Booz Allen Hamilton Holding Corp